Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New scan may predict cancer treatment success

NCT ID NCT01235052

First seen May 17, 2026 · Last updated Jun 16, 2026 · Updated 6 times

Summary

This study looked at whether a special PET scan called FMISO can help predict how well head and neck cancer patients respond to treatment. Sixteen adults with this cancer received the scan before starting radiation therapy. The goal was to see if the scan's results matched their health two years later. The study did not test a new treatment, but aimed to improve how doctors plan radiation therapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHU de Bordeaux - Hôpital Pellegrin

    Bordeaux, 33 076, France

  • Hôpital Robert Picqué

    Villenave-d'Ornon, 33882, France

Conditions

The condition(s) this trial relates to.

head and neck cancer head and neck neoplasm Head and Neck Neoplasms head and neck squamous cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.